Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEFLUNOMIDE vs LETERMOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEFLUNOMIDE vs LETERMOVIR: Safety Overview

Metric LEFLUNOMIDE LETERMOVIR
Total FAERS Reports 56,539 1,416
Deaths Reported 5,283 252
Death Rate 9.3% 17.8%
Hospitalizations 13,923 398
Average Patient Age 51.3 yrs 46.6 yrs
% Female Patients 87.3% 42.7%
FDA Approval Date Apr 24, 2019 Aug 30, 2024
Manufacturer Alembic Pharmaceuticals Inc. Merck Sharp & Dohme LLC
Route ORAL ORAL
Marketing Status Prescription Prescription